Sicagen India Ltd

As of 10-Nov, Sicagen India Ltd is priced at 61.90, showing a slight increase today but has underperformed recently with declines over the past week and month. The stock is trading below all major moving averages, indicating a bearish trend, despite increased investor participation.

Sicagen India's historical performance shows fluctuating net sales and profits, peaking at 895.30 Cr in March 2023 before declining slightly to 891.88 Cr in March 2025. Despite this, operating profit and profit before tax improved, indicating enhanced operational efficiency and a stable financial position.

Sicagen India's latest Q2 FY26 results show a net profit increase of 14.36% to ₹4.54 crores, indicating improved margins, but revenue fell 18.72% quarter-on-quarter, raising concerns about demand sustainability. Overall, while profitability has improved, the significant revenue decline suggests challenges ahead.

Sicagen India has experienced fluctuating net sales, peaking at 895.30 Cr in Mar'23 and declining slightly to 891.88 Cr in Mar'25, while profitability improved, with profit after tax rising to 17.11 Cr in Mar'25 from 10.52 Cr in Mar'24. The company demonstrated better operational efficiency and cash flow management despite slight decreases in total assets and liabilities.

As of 10-Oct, Sicagen India Ltd's stock price is at 65.00, down 1.5% and has declined 5.93% over the last four days. It is trading below all major moving averages, indicating a bearish trend, and has underperformed significantly compared to the Sensex, with a year-to-date decline of 26.04%.

Sicagen India has shown fluctuating historical performance, with net sales increasing to 891.88 crore in March 2025, and significant improvements in profitability, including a profit after tax of 17.11 crore and earnings per share rising to 4.32. Despite rising costs, the company demonstrated resilience with improved cash flow and operating profit.

Sicagen India has shown fluctuating net sales and profits historically, with net sales at 891.88 Cr in March 2025, up from 795.45 Cr in March 2024, and improved profitability, including a profit after tax of 17.11 Cr. Despite some sales fluctuations, the company has demonstrated resilience with enhanced operational efficiency and cash flow.

As of 25-Sep, Sicagen India Ltd's stock price is at 69.20, down 2.33%, with a significant decline over the past week and month. The stock is underperforming compared to the Sensex, indicating specific issues affecting its performance despite broader market conditions.

As of 11-Sep, Sicagen India Ltd's stock price is 75.99, having increased by 0.78% after two days of decline. Despite a year-to-date drop of 13.54%, the company shows strong annual growth in operating profit and an attractive valuation, indicating potential for recovery.

As of 10-Sep, Sicagen India Ltd is priced at 75.40, down 3.33% and has declined 29.55% over the past year, despite a positive monthly return of 7.71%. The stock shows long-term growth potential with a strong operating profit increase, but its year-to-date performance is negative at -14.21%.

As of 09-Sep, Sicagen India Ltd is priced at 78.00, down 0.57%, but has shown strong short-term performance with 1-week and 1-month returns of 4.00% and 11.43%, respectively. Despite a 27.67% decline over the past year, the stock's operating profit has increased by 32.2%, indicating potential undervaluation and strong long-term growth prospects.

As of 08-Sep, Sicagen India Ltd's stock price is Rs 78.45, up 4.09% today and outperforming its sector. Despite a year-to-date decline, the stock shows strong recent performance and favorable valuation metrics, indicating potential undervaluation.

As of 05-Sep, Sicagen India Ltd's stock price is 75.37, down 1.35%, underperforming its sector. Despite recent gains and strong profitability, the stock has declined significantly year-to-date and over the past year, reflecting cautious market sentiment.